DTaP/TAK-361S quadruple vaccine (Takeda)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDTaP/TAK-361S quadruple vaccine (Takeda)

Drug Alias NameQuadruple vaccine including Sabin-IPV - TakedaSabin-IPV-containing vaccines - Takeda/Japan Poliomyelitis Research InstituteTAK-361S

ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Vaccine type > Combination vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPoliomyelitisTetanusDiphtheria +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTakeda Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTakeda Pharmaceutical Co Ltd

Active IndicationsN/A

Inactive IndicationsPoliomyelitisTetanusDiphtheria +[4]

Other Information

ATC CodeN/A